FIELD: medicine.
SUBSTANCE: research concerns medicine area, particularly, to oncology and (Ieper) of a mammary gland can be used for an estimation of probability of a lymphogenous innidiation of infiltrating ductal cancer. Essence of a way: morphological research of assay of an infiltrative component of mammary gland cancer is performed with definition of percentage of microalveolar structures in relation to other allocated structures of a component. At their content less than 10% low, at their content from 11-50% moderate, and at their content of 51-75% and more - high probability of a lymphogenous innidiation of infiltrating ductal mammary gland cancer is determined.
EFFECT: use of the way gives the chance to estimate probability of lymphogenous innidiation of mammary gland with IDC with conservation of sufficient accuracy and informativeness, at simplicity of execution.
11 tbl, 3 ex, 5 dwg
Title | Year | Author | Number |
---|---|---|---|
WAY OF FORECASTING OF DEGREE OF LYMPHOGENOUS INNIDIATION AT INFILTRATIVE DUCTAL MAMMARY GLAND CANCER | 2008 |
|
RU2362996C1 |
METHOD OF EVALUATION OF PROBABILITY OF HEMATOGENIC METASTASIS IN INFILTRATING BREAST DUCT CARCINOMA | 2006 |
|
RU2324180C1 |
METHOD FOR PREDICTION OF LYMPHATIC CANCER SPREAD ACCOMPANIED BY INVASIVE NONSPECIFIC TRIPLE-NEGATIVE BREAST CANCER | 2014 |
|
RU2558860C1 |
METHOD OF PREDICTING NODAL METASTASIS IN TWO-WAY SYNCHRONOUS INVASIVE CARCINOMA OF NON-SPECIFIC TYPE OF MAMMARY GLANDS | 2015 |
|
RU2578462C1 |
METHOD FOR PREDICTION OF HAEMATOGENOUS METASTASIS IN TRIPLE NEGATIVE INVASIVE NON-SPECIFIC BREAST CARCINOMA | 2014 |
|
RU2558863C1 |
METHOD FOR HEMATOGENIC METASTASING PREDICTION IN CASE OF NON-SPECIFIC INVASIVE CARCINOMA OF BREAST IN PATIENTS WITH GOOD RESPONSE TO NEOADJUVANT CHEMOTHERAPY | 2016 |
|
RU2627649C1 |
METHOD FOR PREDICTION OF HAEMATOGENIC METASTASIS IN DOUBLE-SIDED SYNCHRONOUS INVASIVE NON-SPECIFIC BREAST CARCINOMA | 2015 |
|
RU2589287C1 |
METHOD FOR HEMATOGENOUS METASTASIS PREDICTION IN CASE OF NON-SPECIFIC INVASIVE BREAST CARCINOMA FOR PATIENTS WITH BAD RESPONSE TO NEOADJUVANT CHEMOTHERAPY | 2016 |
|
RU2623150C1 |
METHOD FOR PREDICTION OF LYMPHATIC CANCER SPREAD ACCOMPANYING NON-SPECIFIC BREAST CARCINOMA | 2014 |
|
RU2566732C1 |
BREAST CANCER OUTCOME PREDICTION METHOD | 2008 |
|
RU2361222C1 |
Authors
Dates
2009-07-20—Published
2006-06-15—Filed